EXELIXIS, INC. (EXEL)
Clinical trial NCT06957431 updates: 1. completion date: 2033-10-31 → 2036-04-30 2. primary completion date: 2028-11-30 → 2031-05-31
Clinical trial NCT06957431 updates: 1. completion date: 2033-10-31 → 2036-04-30 2. primary completion date: 2028-11-30 → 2031-05-31
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical